Weight loss plus vitamin D reduce cancer-linked chronic inflammation
the ONA take:
According to a new study published online ahead of print in the journal Cancer Prevention Research, researchers at Fred Hutchinson Cancer Research Center in Seattle, Washington, have found that the addition of vitamin D supplementation to weight loss had a greater improvement in chronic inflammation compared with weight loss alone.
Chronic inflammation is known to contribute to the development and progression of some cancers, as well as other diseases.
For the study, researchers enrolled 218 healthy, overweight, postmenopausal women who had insufficient vitamin D levels. All participants participated in a diet and weight loss program and half were randomly assigned to receive vitamin D 2,000 IU daily for 1 year.
Results showed that women who lost 5 to 10% of their body weight and took vitamin D supplementation experienced the greatest reduction in chronic inflammation.
"We were quite surprised to see that vitamin D had an effect on an inflammation biomarker only among women who lost at least 5 percent of their baseline weight," Catherine Duggan, Ph.D., a principal staff scientist in the Public Health Sciences Division at Fred Hutchinson Cancer Research Center said. "That suggests vitamin D can augment the effect of weight loss on inflammation."
Addition of vitamin D supplementation to weight loss had a greater improvement in chronic inflammation.
- Response to Anemia Treatment Differs in Lymphoma, Multiple Myeloma
- Fertility Preservation in Male Adolescents and Young Adults With Cancer
- Impact of Prostate Cancer Diagnosis, Treatment Choice on Quality of Life
- Social, Psychiatric Variables Reduce Cognitive Functioning, QoL in HNC
- Axillary Lymph Node Dissection Predictive for Lymphedema in Breast Cancer
- HPV and Cancer (Fact Sheet)
- Pain Control More Easily Achieved With Nurse-Led Education in Bone Metastases
- Acupuncture an Effective Alternative Treatment for Cancer-Related Fatigue
- Using Nutrition-Based Strategies to Manage Adverse Effects of Cancer
- Palliative Care Associated With Decreased Costs For Patients With Advanced Cancer
- Refined Equation May Obviate Oncotype DX in Breast Cancer Treatment Decisions
- Risk Factors for Brain Metastases in HER2+ Breast Cancer Identified in Analysis
- Intermediate Oncotype DX Scores Prognostic of OS in Early-stage Breast Cancer
- Colorectal Cancer and Dietary Fiber: Source Is More Important Than Amount
- Reduced Delayed Intensification Impacts Risk of Pediatric ALL Relapse
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|